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Epithelial cells form the ﬁrst physiological barrier against invasion by pathogens and the inﬁltration of
allergens. Tight junctions (TJ), a cellecell junctional complex located on the apical side of epithelial cells,
have a critical role in the maintenance of epithelial barrier function. Impaired TJ structures are observed
in patients with asthma, atopic dermatitis and nasal allergy; therefore, the dysfunction of epithelial
barriers might be involved in the initiation or progression of allergic diseases. Protease-containing al-
lergens and environmental pollutants enhance paracellular transport in epithelial cells through
disruption of epithelial barrier function. This suggests that the disruption of TJ leads to the promotion of
allergen delivery into the subepithelia, resulting in the progression of allergic diseases. Thus, protection
of the epithelial barrier function might prevent or inhibit the development or exacerbation of allergic
diseases. Recently, we reported that diesel exhaust particles (DEP), the main component of particulate
patter 2.5, exacerbated allergic rhinitis (AR) in a mouse model through TJ disruption. In addition, we
revealed that the oxidative stress-mediated pathway is involved in the effects caused by DEP and that
nasal treatment with a reactive oxygen species (ROS) scavenger suppressed DEP-induced TJ disruption
and exacerbation of AR. In this review, we focus on the relationship between TJ disruption and allergic
disease. Furthermore, we discuss our recent ﬁndings regarding TJ disruption and the exacerbation of AR.
Copyright © 2017, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Epithelial cells have an important role as a physical barrier to
prevent the entry of pathogens, allergens and other foreign parti-
cles.1 Tight junctions (TJ), cellecell adhesion complexes between
epithelial cells, are important for epithelial barrier function.2
Epithelial TJ disruption has been associated with various human
diseases such as inﬂammatory bowel disease, celiac disease and
functional dyspepsia.3e5 In allergic diseases, TJ disruption is
observed in the epithelial cells of patients with asthma, atopic
dermatitis, and nasal allergy.6e9 Thus, TJ disruption, namely
epithelial barrier dysfunction, is considered involved in the initia-
tion or progression of allergic diseases.y, and Laboratory of Allergic
Hyogo College of Medicine,
o).
ety of Allergology.
rgology. Production and hosting by ElseIt was reported that disruption of the TJ barrier is induced by
proteases present in pollens or house dust mites (HDM), cytokines
or environmental pollutants such as particulate matter (PM) 2.5
and cigarette smoke.10e14 In addition, SNPs of the CLDN1 gene,
encoding claudin-1 that is essential for TJ function, were present in
patients with atopic dermatitis, suggesting genetic factors might
inﬂuence the weakness of TJ.7 Paracellular transport is enhanced in
epithelial cells with disrupted TJ. Therefore, dysfunction of the TJ
barrier might enhance allergen inﬁltration into the subepithelia
and the uptake of allergens by DCs or mast cell degranulation,
resulting in the initiation or exacerbation of allergy.
These ﬁndings indicate that TJ disruption is linked to various
allergic diseases. However, it is unclear whether protection of the TJ
barrier can suppress or prevent allergic diseases. In this review, we
describe the structure and role of TJ, TJ disruption-inducing factors
and relationship between TJ disruption and allergic disease. Finally,
we will introduce our recent ﬁndings regarding nasal TJ disruption
and the exacerbation of AR.vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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TJ, a multiprotein complex located on the apical side of
epithelial cells, mediates cellecell adhesion and tightly regulates
the paracellular transport of ions, water and various molecules.15,16
TJ are essential for paracellular transport and form an epithelial
barrier function against foreign invaders such as pathogens, parti-
cles, and allergens.1
TJ in epithelial cells are composed of three types of trans-
membrane proteins including occludin, claudin and junction
adhesion molecules (JAMs). These transmembrane proteins are
important for sealing the paracellular spaces between epithelial
cells and the regulation of paracellular transport.15,17 In addition, TJ
structures are supported by adaptor proteins in the cytoplasm such
as zonula occludens (ZO) proteins (Fig. 1).15,17
Occludinwas the ﬁrst identiﬁed integral membrane protein that
is ubiquitously expressed in epithelial cells.15,18,16 Occludin has two
extracellular loops and N- and C-terminal cytoplasmic domains.15,18
The C-terminal of occludin is important for direct interactions with
ZO-1, and the N-terminus is involved in the regulation of para-
cellular permeability.15,18
Claudin family members have a short cytoplasmic N-terminal,
two extracellular loops and C-terminal cytoplasmic domains. The
C-terminal of claudins is required for stability and interactions with
ZO-1.19 The claudin family consists of more than 25 members and
the expression pattern of claudin family members varies consid-
erably among tissues.19 The combination of claudin family mem-
bers is thought to determine the selectively or strength of TJ.20,21 It
was shown that claudin-1, -4, -7, -8, -12, -13 and -14 are expressed
in human nasal mucosa.1
JAMs belong to the immunoglobulin superfamily and have a
single transmembrane domain and a PDZ domain-binding motif at
their C-terminal domain, which interacts with ZO-1.22,23 JAMs are
important for cellecell adhesion and junctional assembly in
epithelial cells.22
The adaptor proteins, ZOs, are involved in the connection of
transmembrane proteins and the recruitment of other cytoplasmic
components such as protein kinase (PKC), GTPase and transcription
factors.16 ZOs regulate junction assembly and selective paracellular
permeability by signal transduction.16Fig. 1. Structure of tight junctions in epithelial cells. Tight junctions (TJ) contain three
types of transmembrane proteins: occludins, claudins, and junction adhesion mole-
cules (JAMs) as well as scaffold proteins such as zonula occludens-1 (ZO). ZO proteins
are important for the clustering of occludin and claudin.TJ and dendritic cells in mucosa
DCs also express TJ proteins. It was reported that DCs in the
intestinal mucosa open TJ between epithelial cells, which allows
dendrites to move outside the epithelium to directly uptake bac-
teria.24 Because intestinal DCs express occludin, claudin-1 and ZO-
1, the TJ integrity is preserved when DCs take up bacteria across the
epithelial layer.24 In addition, treatment with thymic stromal
lymphopoietin (TSLP), a proallergic cytokine, enhanced the
expression of claudin family members in DCs in vitro.25 It is unclear
whether DCs in the nasal mucosa directly take up pathogens or
allergens via dendrites that move outside the epithelium. However,
it was reported that, HLA-DR- and CD11c-postitive DCs express
claudin-1 and are increased in human nasal mucosa in patients
with AR compared with healthy subjects.26 This suggests that DCs
in nasal mucosa contribute to preserving the TJ barrier while taking
up allergens in allergic conditions.
TJ disruption-inducing factors
It is well known that protease-containing allergens such as
pollens and HDM, the major allergens for AR, disrupt the TJ barrier.
Cysteine proteases such as Der p1 from fecal pellets of HDM, disrupt
TJ and increase the permeability of Madin-Darby canine kidney
(MDCK) cells and 16HBE14o human bronchial epithelial cell
lines.11 The cleaved fragments of occludin and ZO-1 were detected
by immunoblotting in Der p1-treated 16HBE14o cells in vitro,
suggesting that these TJ-associated proteins are directly proteo-
lyzed by Der p1.11 In addition to HDM, previous reports revealed
that extracts of various pollens impaired TJ barrier functions.10,27
Runswick et al. showed that Giant Ragweed (Ambrosia triﬁda),
White Birch (Betula pendula), and Kentucky Blue Grass (Poa pra-
tensis) decreased the expression of different TJ proteins in MDCK
and Calu-3 cells, human airway epithelial cell lines derived from a
patient with lung adenocarcinoma.10 In addition, these pollen ex-
tracts increased the paracellular permeability of Calu-3 cells.10 The
proteolytic activities of Kentucky Blue Grass pollens were inhibited
by serine (AEBSF), cysteine (E-64) and trypsin-like protease in-
hibitors, suggesting that proteases in pollen extracts directly affect
TJ proteins.10 Another group showed that crude extracts of Olive
tree (Olea europaea), Orchard grass (Dactylis glomerata), Italian cy-
press (Cupressus sempervirens) and Scots pine (Pinus sylvestris)
decreased claudin-1 expression and increased transepithelial
permeability in Calu-3 cells.27 Of note, these pollens had different
effects on claudin-1 expression. Scots pine pollens had a greater
impact on claudin-1 expression than other pollens. Therefore,
although each pollen causes effects on TJ to a different degree, most
pollens can disrupt epithelial TJ barriers.
It was reported that Th2 cytokines such as IL-4 and IL-13 disrupt
TJ in airway epithelial cells.28 IL-4 or IL-13-treated Calu-3 cells
showed signiﬁcantly decreased ZO-1 expression and slightly
decreased occludin expression.28 The TJ barrier function of Calu-
3 cells was also decreased by IL-4- or IL-13-treatment.28 In addition,
it was shown that IL-4 disrupted TJ structures and increased para-
cellular transport in 16HBE14o cells that was JAK-dependent.29 IL-
13 also impaired epithelial TJ barrier in 16HBE14o cells.29 However,
combined IL-4 and IL-13 were not synergistic, suggesting IL-4 and
IL-13 disrupt TJ through the same pathway.29 Similar to 16HBE14o
cells, IL-4 enhanced paracellular transport in primary human nasal
epithelial cells (HNECs).8 However, the effects of Th2 cytokines on TJ
barrier functions in nasal epithelia in vivo are unknown.
Environmental pollutants such as PM2.5 and cigarette smoke
affect the TJ barrier in pulmonary or nasal epithelial cells.12e14
PM2.5 (aerodynamic diameter <2.5 mm) is mainly composed of
diesel exhaust particles produced by motor vehicles and industrial
Fig. 2. Experimental schema for the effect of DEP on the exacerbation of AR. (A) Mice
were sensitized with ragweed pollen (RW) at days 0 and 7. At day 14, mice were
challenged intranasally with RW (0.1 mg) or RW plus DEP (10 mg) for 4 days. The
number of sneezes was counted for 10 min immediately after each challenge. (B) Mice
were sensitized as described in (A). At day 9, sensitized mice were administrated
intranasally with DEP for 4 days, and then challenged with RW.
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absorbed metals and organic chemicals.30 Epidemiological studies
revealed that exposure to PM2.5 increases the risk of allergic dis-
eases, and that the prevalence of AR in urban areas with air
pollution is higher than that in rural areas.32,33 However, it is un-
clear whether DEP-induced TJ disruption is linked to the exacer-
bation of AR. We recently revealed that DEP exacerbated AR by
disrupting TJ barriers in nasal epithelia in vivo.13 Furthermore, the
oxidative stress pathway was involved in the DEP-induced TJ
disruption and exacerbation of AR.13 We will discuss the effect of
DEP on AR in more detail in the following section ‘Epithelia barrier
disruption and allergic diseases’.
Epidemiological studies showed that cigarette smoke is a risk
factor for asthma and chronic rhinosinusitis (CRS) with polyps.14,34
Incubation with cigarette smoke extract decreased ZO-1 and ZO-2
expression, and disrupted TJ barrier function in 16HBE14o cells
and primary human bronchial epithelial cells (pHBECs).14 In addi-
tion, cigarette smoke extract decreased ZO-1 and JAMAs expres-
sions in primary human sinonasal epithelial cells from healthy
subjects.34 The effect of cigarette smoke extract was inhibited by
the pharmacologic activation of nuclear factor erythroid 2-related
factor 2 (Nrf2), which is involved in the anti-oxidant pathway.34
This suggests that cigarette smoke extract disrupts TJ through
oxidative stress similar to DEP.
Epithelia barrier disruption and allergic diseases
It was shown that the disruption of TJ is induced in bronchial
epithelial cells in patients with asthma.6 A previous report showed
that the epithelial barrier function of primary bronchial epithelial
cells from patients with severe asthma was lower than that in
healthy subjects or patients with mild asthma.6 In atopic derma-
titis, claudin-1 and -23 expression were decreased in keratinocytes
frompatients with atopic dermatitis.7 In addition, the association of
atopic dermatitis and four SNPs of the CLDN1 gene (rs17501010,
rs9290927, rs9290929 and rs893051) in African-American atopic
dermatitis patients was previously reported.7 Furthermore,
rs893051 is associated with the early onset of atopic dermatitis.35
Claudin-1 deﬁcient mice die within 1 day of birth because of
excessive transepidermal water loss, severe dehydration and
increased epidermal permeability.36 Thus, the TJ barrier in kerati-
nocytes is important for maintaining the skin barrier and the
dysfunction of TJ might lead to the onset of atopic dermatitis.
In the nose, dysfunction of the nasal epithelial barrier was
observed in patients with HDM-induced AR and chronic rhinosi-
nusitis (CRS) with polyps.8,9 As mentioned above, treatment with
pollen extract Der p1 and IL-4 disrupted TJ in primary human nasal
epithelial cells (HNECs).29 However, it is unknown whether TJ
disruption is directly linked to the exacerbation of AR and whether
protection of the TJ barrier suppresses AR symptoms.
Epithelia barrier disruption and AR
Previous epidemiological studies reported that DEP exacerbate
AR. However, the exact role of DEP in the exacerbation of AR is
unknown. Recently, we revealed that nasal TJ disruption induced by
DEP exacerbated AR using an ARmouse model.13 We will introduce
our recent study regarding TJ disruption and AR symptoms.
First, to investigate whether DEP worsened AR, ragweed-
sensitized mice were simultaneously challenged with ragweed
pollen alone or ragweed pollen plus DEP (Fig. 2A).13 We treated
mice with ragweed pollen at a low dose that barely induced AR
symptoms.13 At the ﬁrst challenge, the frequency of sneezing was
comparable between ragweed-alone- and ragweed-plus-DEP-
challenged mice.13 However, the frequency of sneezing wassigniﬁcantly increased in mice challenged with ragweed pollen
plus DEP (40e60 times), but remained low (10e20 times) in
ragweed-alone-challengedmice during the challenge.13 Although it
was reported that DEP has an adjuvant effect when used in the
sensitization phase,37,38 the production of Th2 cytokines (IL-4, IL-5
and IL-13) from cervical lymph nodes and serum IgE levels were
comparable between the groups.13 These results reveal that the
DEP-mediated exacerbation of AR is not caused by the adjuvant
activity of DEP.
DEP might not always be inhaled concurrent with allergen
exposure by rhinitis patients. Thus, we next treated sensitized mice
with DEP before ragweed pollen-challenge (Fig. 2B). Pretreatment
with DEP also increased the frequency of sneezing.13 Remarkably,
although the co-administration of DEP did not increase sneezing
frequency at the ﬁrst ragweed-challenge, mice pretreated with DEP
showed a remarkably increased frequency of sneezing at all time
points.
DEP impairs nasal epithelial barrier functions
It was shown that DEP disrupt TJ in pulmonary epithelial cells
in vitro.12 We analysed the effect of DEP on TJ in nasal epithelial
cells. Monolayer RPMI 2650 cells, a human nasal epithelial cell line,
were treated with DEP for 24 h, and TJ structure and epithelial
barrier function in RPMI 2650 cells were analysed. We used three
methods for the analysis of TJ in RPMI 2650 cells: immunostaining
for ZO-1, measurement of Transepithelial Electric Resistance (TER)
and permeability of FITC-dextran (Fig. 3).13 At 24 h after DEP-
treatment, the expression of ZO-1 was decreased and TER was
Fig. 3. Analysis of nasal epithelial barrier function. Monolayer RPMI 2650 cells cultured in upper wells were treated with DEP for 24 h. Immunostaining for ZO-1 (A). Transepithelial
electric resistance (TER) was measured (B). After 24 h of DEP treatment, RPMI 2650 cells were incubated with FITC-dextran for 3 h, and then culture supernatants were collected.
Fluorescence intensity in culture supernatants was measured (C).
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dextran, at 24 h after DEP-treatment, FITC-dextran was added
into upper wells for 3 h, and then the ﬂuorescence intensity of FITC
in bottom wells, which passed through epithelial layer, was
measured. DEP-treated RPMI 2650 cells had an increased perme-
ability to FITC-dextran.13
To conﬁrm the effect of DEP on nasal TJ in vivo, we analysed
ZO-1 expression in nasal epithelia from mice treated with DEP.
Immunohistochemistry analysis showed that ZO-1 expression in
nasal epithelia was decreased by treatment of DEP alone for 4 days,
while ragweed pollen-alone-challenge did not inﬂuence TJ.13
Moreover, a single treatment of DEP was sufﬁcient to disrupt
nasal TJ. Next, we investigated whether decreased ZO-1 expression
correlated with increased sneezing. Ragweed-sensitized mice
were treated with a single DEP exposure, and ZO-1 expression in
nasal epithelia and the frequency of sneezing at days 2, 4, 6, and 8
after DEP treatment were analysed (Fig. 4). ZO-1 expression was
signiﬁcantly decreased at days 2 and 4; however, ZO-1 expression
recovered 6 days after the single exposure of DEP.13 Furthermore,
the frequency of sneezing was increased at days 2 and 4, but an
increased frequency was not observed at days 6 and 8.13 Thus,
decreased ZO-1 expression and increased sneezing were inversely
correlated, indicating the involvement of TJ disruption in the
exacerbation of AR (Fig. 5).Fig. 4. Experimental schema for determining the relationship between TJ disruption
and exacerbation of AR. Sensitized mice as described in Fig. 2A were intranasally
administrated with DEP at days 8, 10, 12 or 14. At day 16, mice were challenged with
RW, and the frequency of sneezing was counted and ZO-1 expression was analysed.Nasal TJ disruption by DEP is induced by a reactive oxygen
species (ROS)-mediated pathway
Next, to identify the pathway involved in DEP-induced TJ
disruption, we focused on ROS production. Previous reports sug-
gested that DEP decreased the expression of TJ proteins in pulmo-
nary epithelial cells in vitro through oxidative stress.39,40 Thus, we
treated RPMI 2650 cells with N-acetyl-L-cysteine (NAC), a ROS
scavenger, together with DEP. NAC-treated RPMI 2650 cells did not
show a DEP-induced decrease of ZO-1 expression or increased
permeability to FITC-dextran.13 Furthermore, in vivo intranasal
treatment with NAC prevented the DEP-induced increase in
sneezing and decrease in ZO-1 expression in nasal epithelia.13
Therefore, DEP disrupts nasal TJ by a ROS-mediated pathway, and
nasal treatment with NAC might be a novel therapeutic strategy for
the DEP-induced exacerbation of AR.
Conclusions
In this review, we described the importance of epithelial barrier
and the relationship between TJ disruption and allergic diseases. In
addition, we discussed our new ﬁndings regarding the association of
TJ disruption and exacerbation of AR induced by DEP. Our study
revealed that ROS production is involved in DEP-induced TJ disrup-
tion and the exacerbation of AR. In addition, a ROS scavenger, NAC,
was effective against the DEP-induced exacerbation of AR, suggest-
ing that protection of the TJ barrier might suppress or prevent AR.
Dysfunction of the TJ barrier was observed in patients with
various allergic diseases. Our study showed that the intranasal
administration of NAC prevented DEP-induced TJ disruption,
resulting in suppression of the exacerbation of AR. However, the TJ
barrier is impaired by ROS production as well as direct proteolysis
by proteases or Th2 cytokine-mediated pathways. Thus, a combi-
nation of protease inhibitor and the neutralization of Th2 cytokines
might be effective for AR induced by protease-containing allergens.
Although further studies are needed, protection of the nasal TJ
barrier might be a promising approach for the development of
therapeutic or preventive strategies for AR.
Fig. 5. Schematic diagram of DEP-induced TJ disruption and exacerbation of AR. Without DEP exposure, the penetration of allergens is prevented by the TJ barrier. Nasal TJ are
disrupted by ROS production when nasal mucosa are exposed to DEP. The disruption allows allergens to penetrate into the subepithelial tissue, resulting in increased sneezing.
A. Fukuoka, T. Yoshimoto / Allergology International 67 (2018) 18e2322Acknowledgements
This work was supported by a Grant-in-Aid for Scientiﬁc
Research B (15K19139) from the Japan Society for the Promotion of
Science. We thank J. Ludovic Croxford, PhD, from Liwen Bianji,
Edanz Group China (www.liwenbianji.cn/ac), for editing the En-
glish text of a draft of this manuscript.Conﬂict of interest
The authors have no conﬂict of interest to declare.References
1. Kojima T, Go M, Takano K, Kurose M, Ohkuni T, Koizumi J, et al. Regulation of
tight junctions in upper airway epithelium. Biomed Res Int 2013;2013:947072.
2. Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma
immunology and allergic airway inﬂammation. J Allergy Clin Immunol
2014;134:509e20.
3. Salim SY, Soderholm JD. Importance of disrupted intestinal barrier in inﬂam-
matory bowel diseases. Inﬂamm Bowel Dis 2011;17:362e81.
4. Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita AV,
et al. Impaired duodenal mucosal integrity and low-grade inﬂammation in
functional dyspepsia. Gut 2014;63:262e71.
5. Schumann M, Kamel S, Pahlitzsch ML, Lebenheim L, May C, Krauss M, et al.
Defective tight junctions in refractory celiac disease. Ann N Y Acad Sci
2012;1258:43e51.
6. Xiao C, Puddicombe SM, Field S, Haywood J, Broughton-Head V, Puxeddu I,
et al. Defective epithelial barrier function in asthma. J Allergy Clin Immunol
2011;128:549-56. e1e12.
7. De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C, et al.
Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol
2011;127:773-86. e1e7.
8. Steelant B, Farre R, Wawrzyniak P, Belmans J, Dekimpe E, Vanheel H, et al.
Impaired barrier function in patients with house dust mite-induced allergic
rhinitis is accompanied by decreased occludin and zonula occludens-1
expression. J Allergy Clin Immunol 2016;137:1043-53. e5.
9. Soyka MB, Wawrzyniak P, Eiwegger T, Holzmann D, Treis A, Wanke K, et al.
Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight
junctions by IFN-gamma and IL-4. J Allergy Clin Immunol 2012;130:1087-96.
e10.
10. Runswick S, Mitchell T, Davies P, Robinson C, Garrod DR. Pollen proteolytic
enzymes degrade tight junctions. Respirology 2007;12:834e42.
11. Wan H,Winton HL, Soeller C, Tovey ER, Gruenert DC, Thompson PJ, et al. Der p 1
facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin
Invest 1999;104:123e33.
12. Lehmann AD, Blank F, Baum O, Gehr P, Rothen-Rutishauser BM. Diesel exhaust
particles modulate the tight junction protein occludin in lung cells in vitro. Part
Fibre Toxicol 2009;6:26.
13. Fukuoka A, Matsushita K, Morikawa T, Takano H, Yoshimoto T. Diesel exhaust
particles exacerbate allergic rhinitis in mice by disrupting the nasal epithelial
barrier. Clin Exp Allergy 2016;46:142e52.
14. Schamberger AC, Mise N, Jia J, Genoyer E, Yildirim AO, Meiners S, et al. Ciga-
rette smoke-induced disruption of bronchial epithelial tight junctions isprevented by transforming growth factor-beta. Am J Respir Cell Mol Biol
2014;50:1040e52.
15. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev
Mol Cell Biol 2001;2:285e93.
16. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol
2003;4:225e36.
17. Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of
tight junctions. Biochim Biophys Acta 2008;1778:588e600.
18. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, et al. Occludin:
a novel integral membrane protein localizing at tight junctions. J Cell Biol
1993;123:1777e88.
19. Gunzel D, Yu AS. Claudins and the modulation of tight junction permeability.
Physiol Rev 2013;93:525e69.
20. Amasheh S, Meiri N, Gitter AH, Schoneberg T, Mankertz J, Schulzke JD, et al.
Claudin-2 expression induces cation-selective channels in tight junctions of
epithelial cells. J Cell Sci 2002;115:4969e76.
21. Wen H, Watry DD, Marcondes MC, Fox HS. Selective decrease in paracellular
conductance of tight junctions: role of theﬁrst extracellular domain of claudin-5.
Mol Cell Biol 2004;24:8408e17.
22. Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, Pendl GG, Vestweber D. Junc-
tional adhesion molecule interacts with the PDZ domain-containing proteins
AF-6 and ZO-1. J Biol Chem 2000;275:27979e88.
23. Williams AF, Barclay AN. The immunoglobulin superfamilyedomains for cell
surface recognition. Annu Rev Immunol 1988;6:381e405.
24. Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, et al.
Dendritic cells express tight junction proteins and penetrate gut epithelial
monolayers to sample bacteria. Nat Immunol 2001;2:361e7.
25. Kamekura R, Kojima T, Takashima A, Koizumi J, Ogasawara N, Go M, et al.
Thymic stromal lymphopoietin induces tight junction protein claudin-7 via NF-
kappaB in dendritic cells. Histochem Cell Biol 2010;133:339e48.
26. Takano K, Kojima T, Go M, Murata M, Ichimiya S, Himi T, et al. HLA-DR- and
CD11c-positive dendritic cells penetrate beyond well-developed epithelial
tight junctions in human nasal mucosa of allergic rhinitis. J Histochem Cytochem
2005;53:611e9.
27. Vinhas R, Cortes L, Cardoso I, Mendes VM, Manadas B, Todo-Bom A, et al. Pollen
proteases compromise the airway epithelial barrier through degradation of
transmembrane adhesion proteins and lung bioactive peptides. Allergy
2011;66:1088e98.
28. Ahdieh M, Vandenbos T, Youakim A. Lung epithelial barrier function and
wound healing are decreased by IL-4 and IL-13 and enhanced by IFN-gamma.
Am J Physiol Cell Physiol 2001;281:C2029e38.
29. Saatian B, Rezaee F, Desando S, Emo J, Chapman T, Knowlden S, et al. Inter-
leukin-4 and interleukin-13 cause barrier dysfunction in human airway
epithelial cells. Tissue Barriers 2013;1:e24333.
30. Pandya RJ, Solomon G, Kinner A, Balmes JR. Diesel exhaust and asthma: hy-
potheses and molecular mechanisms of action. Environ Health Perspect
2002;110:103e12.
31. Diaz-Sanchez D, Proietti L, Polosa R. Diesel fumes and the rising prevalence of
atopy: an urban legend? Curr Allergy Asthma Rep 2003;3:146e52.
32. Morgenstern V, Zutavern A, Cyrys J, Brockow I, Koletzko S, Kramer U, et al.
Atopic diseases, allergic sensitization, and exposure to trafﬁc-related air
pollution in children. Am J Respir Crit Care Med 2008;177:1331e7.
33. Kramer U, Koch T, Ranft U, Ring J, Behrendt H. Trafﬁc-related air pollution is
associated with atopy in children living in urban areas. Epidemiology 2000;11:
64e70.
34. Tharakan A, Halderman AA, Lane AP, Biswal S, Ramanathan Jr M. Reversal of
cigarette smoke extract-induced sinonasal epithelial cell barrier dysfunction
through Nrf2 Activation. Int Forum Allergy Rhinol 2016;6:1145e50.
A. Fukuoka, T. Yoshimoto / Allergology International 67 (2018) 18e23 2335. Asad S, Winge MC, Wahlgren CF, Bilcha KD, Nordenskjold M, Taylan F, et al. The
tight junction gene Claudin-1 is associated with atopic dermatitis among
Ethiopians. J Eur Acad Dermatol Venereol 2016;30:1939e41.
36. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, et al. Claudin-
based tight junctions are crucial for the mammalian epidermal barrier: a lesson
from claudin-1-deﬁcient mice. J Cell Biol 2002;156:1099e111.
37. Alessandrini F, Schulz H, Takenaka S, Lentner B, Karg E, Behrendt H, et al. Ef-
fects of ultraﬁne carbon particle inhalation on allergic inﬂammation of the
lung. J Allergy Clin Immunol 2006;17:824e30.38. Brandt EB, Kovacic MB, Lee GB, Gibson AM, Acciani TH, Le Cras TD, et al. Diesel
exhaust particle induction of IL-17A contributes to severe asthma. J Allergy Clin
Immunol 2013;132:1194e204. e2.
39. Caraballo JC, Borcherding J, Thorne PS, Comellas AP. Protein kinase C-zeta
mediates lung injury induced by diesel exhaust particles. Am J Respir Cell Mol
Biol 2013;48:306e13.
40. Xu R, Li Q, Zhou XD, Perelman JM, Kolosov VP. Oxidative stress mediates the
disruption of airway epithelial tight junctions through a TRPM2-PLCgamma1-
PKCalpha signaling pathway. Int J Mol Sci 2013;14:9475e86.
